Standard Operating Procedure for CMC Change Documentation for Registered Products
| Department | Regulatory Affairs |
| SOP No. | RA/2026/709 |
| Supersedes | NA |
| Page No. | 1 of X |
| Issue Date | 13/04/2026 |
| Effective Date | 13/04/2026 |
| Review Date | 13/04/2028 |
Purpose
This Standard Operating Procedure (SOP) establishes a systematic and controlled process for managing Chemistry, Manufacturing, and Controls (CMC) change documentation related to registered pharmaceutical products. It ensures all changes are documented, evaluated, approved, and communicated in accordance with regulatory requirements, supporting product quality, safety, and compliance throughout the product lifecycle.
Scope
This SOP applies to all CMC changes involving registered pharmaceutical products within the organization, including changes to formulation, manufacturing process, packaging, specifications, analytical methods, and stability data. It is relevant to regulatory affairs, quality assurance, manufacturing, quality control, and associated departments responsible for initiating, reviewing, approving, and submitting CMC change documentation to health authorities. This procedure excludes changes related to clinical trial materials or non-registered developmental products.
Responsibilities
The responsibilities for CMC change documentation include but are not limited to:
- Regulatory Affairs: Prepare, compile, review, and submit CMC change documentation to regulatory agencies as per guidelines.
- Quality Assurance: Review and approve the change documentation ensuring compliance with quality systems and regulatory expectations.
- Manufacturing Department: Provide technical details and justifications supporting the changes in manufacturing processes or controls.
- Quality Control: Provide analytical validation and testing data pertinent to the proposed changes.
- Project/Change Management: Coordinate cross-functional communications and ensure timely progress of the change documentation process.
Accountability
The Regulatory Affairs Head is accountable for the implementation, compliance, periodic review, escalation of deviations, and ensuring the effectiveness of this SOP. They oversee governance of CMC change documentation management and ensure alignment with current regulatory requirements and internal policies.
Procedure
1. Initiation: Upon identification of a potential CMC change to a registered product, the responsible department submits a Change Request Form outlining the scope, purpose, and impact assessment of the proposed change.
2. Impact Assessment: Cross-functional teams including Regulatory Affairs, Quality Assurance, Manufacturing, and Quality Control conduct a thorough impact assessment covering product quality, safety, efficacy, regulatory implications, timelines, and risk management.
3. Preparation of Change Documentation: Regulatory Affairs consolidates all relevant technical data, validation results, stability data, and regulatory justifications into the CMC change document package. This includes updated dossiers, summaries, and cover letters tailored to the applicable regulatory authority submission format.
4. Review and Approval: The assembled documentation undergoes detailed review by Quality Assurance and other key stakeholders for accuracy, completeness, and compliance. Necessary revisions are made before formal approval.
5. Regulatory Submission: Following approver authorization, Regulatory Affairs submits the CMC change documentation to the concerned health authorities adhering to specified timelines and formats.
6. Post-Submission Follow-up: Regulatory Affairs monitors the submission status, responds promptly to queries or inspection findings, and coordinates any additional data requests or updates.
7. Record Keeping and Closure: All relevant documents, including Change Request Forms, impact assessments, approvals, submission receipts, correspondence, and final regulatory approvals, are archived as per document retention policies. The change process is formally closed upon regulatory approval or acknowledgment.
Throughout all steps, ensure compliance with Good Manufacturing Practices (GMP) and Good Documentation Practices (GDP). Deviations, change control exceptions, or delays are documented, investigated, and escalated as per internal policies. Training is provided to all involved personnel on updated procedures and regulatory requirements to maintain compliant and efficient change management processes.
Abbreviations
CMC – Chemistry, Manufacturing, and Controls
GMP – Good Manufacturing Practice
GDP – Good Documentation Practice
QA – Quality Assurance
QC – Quality Control
SOP – Standard Operating Procedure
Documents
- Change Request Form for Registered Product (Annexure-1)
- Impact Assessment Report Template (Annexure-2)
- CMC Change Submission Checklist (Annexure-3)
References
ICH Q7 – Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
ICH Q9 – Quality Risk Management
ICH Q10 – Pharmaceutical Quality System
US FDA Guidance for Industry: Post-approval Changes
EMA Guidelines on Variations to Marketing Authorizations
Company Quality Management System Documentation
Version
1.0
Approval
| Prepared By | |
| Checked By | |
| Approved By |
Annexures
Annexure-1: Change Request Form for Registered Product
Purpose: To initiate and formally document proposed CMC changes to registered products for evaluation and regulatory submission.
| Change Request No. | CR-2026-001 |
| Date of Request | 13/04/2026 |
| Product Name | Example Registered Product |
| Proposed Change Description | Update in capsule coating formulation |
| Reason for Change | Improve stability under accelerated conditions |
| Change Originator Dept. | Manufacturing |
| Impact Assessment Required | Yes |
| Requested By | Functional Dept. Head |
| Signature | __________________ |
| Date | 13/04/2026 |
Annexure-2: Impact Assessment Report Template
Purpose: To evaluate and document the potential impact of proposed CMC changes on product quality, regulatory compliance, timelines, and patient safety.
| Assessment Element | Details |
|---|---|
| Product/Batch Affected | Example Registered Product / Batch #12345 |
| Change Description | Modification of coating formulation |
| Quality Impact | Improved dissolution profile expected, no adverse impact anticipated |
| Regulatory Impact | Requires variation submission to health authority |
| Risk Level | Low to Moderate |
| Timeline Impact | Estimated 3 months for regulatory approval |
| Mitigation Measures | Stability testing under accelerated and long-term conditions |
| Approval Signatures | QA: ___________ Regulatory Affairs: ___________ |
| Date | 13/04/2026 |
Annexure-3: CMC Change Submission Checklist
Purpose: To ensure completeness and compliance of all documentation required for CMC change submission to regulatory agencies.
| Checklist Item | Status (Yes/No) | Comments |
|---|---|---|
| Change Request Form Completed | Yes | |
| Impact Assessment Report Included | Yes | |
| Product Technical Dossier Updated | No | In progress |
| Validation/Analytical Data Attached | Yes | |
| Cover Letter Drafted | Yes | |
| Internal Approvals Obtained | Yes | |
| Regulatory Submission Format Verified | Yes | |
| Submission Acknowledgement Received | Pending |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
| 13/04/2026 | 1.0 | Initial issue | New SOP creation |